✦ LIBER ✦

FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II study

✍ Scribed by Zaniboni, Alberto; Aitini, Enrico; Barni, Sandro; Ferrari, Daris; Cascinu, Stefano; Catalano, Vincenzo; Valmadre, Giuseppe; Ferrara, Domenica; Veltri, Enzo; Codignola, Claudio; Labianca, Roberto

Book ID: 113028100
Publisher: Springer
Year: 2012
Tongue: English
Weight: 179 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-012-1875-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II study of flutamide as second li

Phase II study of flutamide as second line chemotherapy in patients with advanced pancreatic cancer

✍ Jivesh J. Sharma; Betty Razvillas; C.D. Stephens; Susan G. Hilsenbeck; Ashu Shar 📂 Article 📅 1997 🏛 Springer US 🌐 English ⚖ 37 KB

A phase II study: docetaxel as first-lin

A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma

✍ P. Rougier; A. Adenis; M. Ducreux; M. de Forni; J. Bonneterre; M. Dembak; P. Clo 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 153 KB

Gemcitabine and oxaliplatin combination

Gemcitabine and oxaliplatin combination as first-line treatment for advanced pancreatic cancer: a multicenter phase II study

✍ Kyung Hee Lee; Min Kyoung Kim; Yeol Hong Kim; Baek Yeol Ryoo; Ho Yeong Lim; Hong 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 341 KB

Single-agent irinotecan or 5-fluorouraci

Single-agent irinotecan or 5-fluorouracil and leucovorin (FOLFIRI) as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis

✍ Stephen J. Clarke; Sonia Yip; Chris Brown; Guy A. van Hazel; David T. Ransom; Da 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 530 KB

A phase II multicenter study of combined

A phase II multicenter study of combined topotecan and gemcitabine as first line chemotherapy for advanced non-small cell lung cancer

✍ Joppert, M 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 101 KB

A multicenter phase II clinical study of

A multicenter phase II clinical study of oxaliplatin, folinic acid, and 5-fluorouracil combination chemotherapy as second-line treatment for advanced colorectal cancer: A Japanese experience

✍ Yutaka Ogata; Shoji Tokunaga; Yasunori Emi; Eiji Oki; Hiroshi Saeki; Ken Shirabe 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 188 KB